“ MADHUMEHA (DIABETES MELLITUS) AN AYURVEDIC REVIEW”

2021 ◽  
pp. 95-97
Author(s):  
Sunanda Pedhekar ◽  
Pratik Taksale

Diabetes mellitus is one of the global health problem of present era resulting in serious long term complications such as heart disease, neuropathy, nephropathy, retinopathy and even death. In Ayurveda, Madhumeha is mentioned one of the important diseases in which quantity and frequency of urination increase. Diabetes is a metabolic disorder result in deciency or dysfunction of the insulin production. in Ayurveda there are 20 types of Prameha are described which are in generally described by production of excess amount of urine and increased frequency of micturition the twenty Prameha when if not treated is converted into Madhumeha. Madhumeha is a type of Vataja prameha. In Ayurvedic literature have the knowledge about causes, risk factors, prevention and treatment of Madhumeha.

Diabetes is a leading global health problem. Clinicians and most patients are aware that diabetes can lead to complications in the heart, kidneys, and eyes. Given the high morbidity and mortality, much effort is made to screen for and treat these complications. Other organ systems can also be affected by diabetes. The pathogenesis and risk factors for developing these other complications does not always match those for heart, kidneys, and eyes. Additionally, treatment for these other complications is often limited or absent. Here we will review some of the major musculoskeletal, neuropathic, and skin complications linked to diabetes.


2021 ◽  
Vol 97 (2) ◽  
pp. 108-114
Author(s):  
Ágnes Tósaki ◽  
◽  
Éva Remenyik

Viral infections are increasingly a global health problem, but not only because of the current COVID pandemic and acute diseases, but also because of the long-term consequences. The authors shortly describe the main characteristics of hepatitis B and C and tropical viral diseases (dengue, Zika, chikungunya), focusing on dermatological symptoms and also provide a brief current literature review, as well as national aspects related to each pathogen.


Metallomics ◽  
2021 ◽  
Vol 13 (4) ◽  
Author(s):  
James P C Coverdale ◽  
Collette S Guy ◽  
Hannah E Bridgewater ◽  
Russell J Needham ◽  
Elizabeth Fullam ◽  
...  

Abstract The treatment of tuberculosis (TB) poses a major challenge as frontline therapeutic agents become increasingly ineffective with the emergence and spread of drug-resistant strains of Mycobacterium tuberculosis (Mtb). To combat this global health problem, new antitubercular agents with novel modes of action are needed. We have screened a close family of 17 organometallic half-sandwich Os(II) complexes [(arene)Os(phenyl-azo/imino-pyridine)(Cl/I)]+Y– containing various arenes (p-cymene, biphenyl, or terphenyl), and NMe2, F, Cl, or Br phenyl or pyridyl substituents, for activity towards Mtb in comparison with normal human lung cells (MRC5). In general, complexes with a monodentate iodido ligand were more potent than chlorido complexes, and the five most potent iodido complexes (MIC 1.25–2.5 µM) have an electron-donating Me2N or OH substituent on the phenyl ring. As expected, the counter anion Y (PF6–, Cl–, I–) had little effect on the activity. The pattern of potency of the complexes towards Mtb is similar to that towards human cells, perhaps because in both cases intracellular thiols are likely to be involved in their activation and their redox mechanism of action. The most active complex against Mtb is the p-cymene Os(II) NMe2-phenyl-azopyridine iodido complex (2), a relatively inert complex that also exhibits potent activity towards cancer cells. The uptake of Os from complex 2 by Mtb is rapid and peaks after 6 h, with temperature-dependence studies suggesting a major role for active transport. Significance to Metallomics Antimicrobial resistance is a global health problem. New advances are urgently needed in the discovery of new antibiotics with novel mechanisms of action. Half-sandwich organometallic complexes offer a versatile platform for drug design. We show that with an appropriate choice of the arene, an N,N-chelated ligand, and monodentate ligand, half-sandwich organo–osmium(II) complexes can exhibit potent activity towards Mycobacterium tuberculosis (Mtb), the leading cause of death from a single infectious agent. The patterns of activity of the 17 azo- and imino-pyridine complexes studied here towards Mtb and normal lung cells suggest a common redox mechanism of action involving intracellular thiols.


2021 ◽  
Vol 141 ◽  
pp. 243-254
Author(s):  
Sila Ozlem Sener ◽  
Ufuk Ozgen ◽  
Seyda Kanbolat ◽  
Nuriye Korkmaz ◽  
Merve Badem ◽  
...  

2002 ◽  
pp. 545-551 ◽  
Author(s):  
M Bluher ◽  
T Klemm ◽  
T Gerike ◽  
H Krankenberg ◽  
G Schuler ◽  
...  

OBJECTIVE: Recent evidence indicates that peroxisome proliferator-activated receptor-gamma (PPARgamma) is expressed at high levels in foam cells of atherosclerotic lesions, that PPARgamma agonists may directly modulate vessel wall function and that mutations in the PPARgamma-2 gene are associated with a reduced risk of coronary artery disease. METHODS: We investigated whether known variants in the PPARgamma-2 gene are associated with the occurrence of coronary heart disease (CHD) in 365 patients with type 2 diabetes, prospectively characterised for the presence or absence of CHD. The Pro115Gln, Pro12Ala, Pro467Leu, Val290Met mutations and two polymorphisms C478T and C161T of the PPARgamma-2 gene were examined using PCR, denaturing gradient gel electrophoresis and direct sequencing. RESULTS: The distribution of the Pro12Ala, Ala12Ala, C161T and T161T variants was not significantly different between patients with and without CHD, independent of the gender. The Pro12Ala (P=0.011) and the Ala12Ala (P=0.006) variant were associated with a higher body mass index (BMI) compared with the Pro12Pro genotype. A multiple logistic regression analysis introducing the typical risk factors for CHD (age, sex, hypertension, smoking, BMI >26 kg/m2, elevated low density lipoprotein cholesterol and haemoglobin A1c >7%) identified age >60, male gender, hypertension and a higher BMI, but not the PPARgamma-2 variants, as significant risk factors for CHD in our study groups. CONCLUSION: The PPARgamma-2 genotype was not associated with an increased or reduced risk of the occurrence of CHD and can therefore not be regarded as an independent risk factor for CHD in patients with diabetes mellitus.


Sign in / Sign up

Export Citation Format

Share Document